Xiaoju Lv

492 total citations
25 papers, 204 citations indexed

About

Xiaoju Lv is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Xiaoju Lv has authored 25 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Xiaoju Lv's work include Fungal Infections and Studies (9 papers), Antifungal resistance and susceptibility (8 papers) and Pneumonia and Respiratory Infections (3 papers). Xiaoju Lv is often cited by papers focused on Fungal Infections and Studies (9 papers), Antifungal resistance and susceptibility (8 papers) and Pneumonia and Respiratory Infections (3 papers). Xiaoju Lv collaborates with scholars based in China, United States and Hong Kong. Xiaoju Lv's co-authors include Junyan Qu, Guangmin Tang, Xi-Jiao Liu, Zhenzhen Liu, Xiaoli Zhang, Jingwen Jiang, Mark H. Wilcox, Yanbin Liu, Zhu Chen and William O’Riordan and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.

In The Last Decade

Xiaoju Lv

21 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoju Lv China 9 96 96 26 25 22 25 204
Rosa Díaz United States 8 46 0.5× 47 0.5× 31 1.2× 24 1.0× 26 1.2× 14 221
Kirsten van de Groep Netherlands 9 144 1.5× 41 0.4× 19 0.7× 12 0.5× 32 1.5× 13 267
Hideki Ikeda Japan 9 86 0.9× 81 0.8× 19 0.7× 22 0.9× 42 1.9× 33 247
Hari Polenakovik United States 9 60 0.6× 110 1.1× 9 0.3× 29 1.2× 20 0.9× 27 208
Biljana Gillmeister Canada 8 109 1.1× 74 0.8× 20 0.8× 34 1.4× 28 1.3× 15 346
Adrien Contejean France 8 67 0.7× 46 0.5× 17 0.7× 12 0.5× 13 0.6× 29 195
S. Neuville France 8 141 1.5× 105 1.1× 20 0.8× 15 0.6× 7 0.3× 18 248
Clément Ourghanlian France 7 47 0.5× 114 1.2× 29 1.1× 8 0.3× 15 0.7× 14 213
Sanjay Biswas India 11 106 1.1× 61 0.6× 15 0.6× 35 1.4× 20 0.9× 41 330
Małgorzata Mikaszewska-Sokolewicz Poland 8 147 1.5× 37 0.4× 13 0.5× 29 1.2× 20 0.9× 24 274

Countries citing papers authored by Xiaoju Lv

Since Specialization
Citations

This map shows the geographic impact of Xiaoju Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoju Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoju Lv more than expected).

Fields of papers citing papers by Xiaoju Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoju Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoju Lv. The network helps show where Xiaoju Lv may publish in the future.

Co-authorship network of co-authors of Xiaoju Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoju Lv. A scholar is included among the top collaborators of Xiaoju Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoju Lv. Xiaoju Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yanan, et al.. (2025). Clinical features of patients with fungal infections caused by CARD9 deficiency: a literature review of case reports. Frontiers in Cellular and Infection Microbiology. 15. 1615929–1615929.
2.
Zhang, Xiaoxia, et al.. (2024). Fighting against Clostridioides difficile infection: Current medications. International Journal of Antimicrobial Agents. 64(1). 107198–107198. 4 indexed citations
3.
Xiong, Pei, Wei Jiang, Qingmin Zeng, et al.. (2024). Non-obese non-alcoholic fatty liver disease and the risk of chronic kidney disease: a systematic review and meta-analysis. PeerJ. 12. e18459–e18459. 1 indexed citations
4.
Qu, Junyan, Huan Xu, & Xiaoju Lv. (2022). Disseminated alveolar echinococcosis in a patient diagnosed by metagenomic next-generation sequencing: A case report. Frontiers in Public Health. 10. 972619–972619. 3 indexed citations
5.
Qu, Junyan, Fang He, Huan Li, & Xiaoju Lv. (2022). Emergent Virus Reactivation in SARS-CoV-2-Negative Community Acquired Pneumonia Patients During the COVID-19 Pandemic. Frontiers in Microbiology. 13. 758073–758073.
7.
Lv, Xiaoju, Qin Zheng, Qian Wu, et al.. (2022). Case Report: Visceral Leishmaniasis-associated Hemophagocytic Lymphohistiocytosis in Adults: A Case Series and Literature Review. American Journal of Tropical Medicine and Hygiene. 107(6). 1203–1209. 4 indexed citations
8.
Qu, Junyan, Xi-Jiao Liu, & Xiaoju Lv. (2021). Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China. Frontiers in Cellular and Infection Microbiology. 11. 770551–770551. 7 indexed citations
9.
Qu, Junyan & Xiaoju Lv. (2021). The Response Measures to the Coronavirus Disease 2019 Outbreak in China. Open Forum Infectious Diseases. 8(2). ofab014–ofab014. 5 indexed citations
10.
Qu, Junyan, Jingwen Jiang, & Xiaoju Lv. (2020). The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study. BMC Infectious Diseases. 20(1). 571–571. 11 indexed citations
11.
Zhou, Ying, Hui Ye, Yanbin Liu, et al.. (2020). Retrospective analysis of 1,641 cases of classic fever of unknown origin. Annals of Translational Medicine. 8(11). 690–690. 20 indexed citations
12.
Qu, Junyan, et al.. (2020). Clinical analysis in immunocompetent and immunocompromised patients with pulmonary cryptococcosis in western China. Scientific Reports. 10(1). 9387–9387. 27 indexed citations
14.
Lv, Xiaoju, Jeff Alder, Li Li, et al.. (2019). Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection. Antimicrobial Agents and Chemotherapy. 63(7). 25 indexed citations
15.
Li, Yueming, et al.. (2019). Carbon Nano-Onions Embedded CuO Nanosheets: An Excellent Stable Anode Material for Lithium Ion Battery. IOP Conference Series Materials Science and Engineering. 484. 12005–12005. 2 indexed citations
17.
Liu, Yiqiong, et al.. (2017). Analysis on clinical characteristics and drug resistance of Candida parapsilosis bloodstream infections in West China Hospital, China, from 2012 to 2015. Journal de Mycologie Médicale. 28(1). 222–226. 9 indexed citations
18.
Liang, Huang, Hui Ye, Junyan Qu, et al.. (2015). Analysis of cerebrospinal fluid protein concentrations of patients with cryptococcal meningitis treated with antifungal agents. BMC Infectious Diseases. 15(1). 333–333. 6 indexed citations
19.
Zhao, Xu, Jufang Wu, Qingyu Xiu, et al.. (2013). A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia. Diagnostic Microbiology and Infectious Disease. 80(2). 141–147. 20 indexed citations
20.
Yang, Heping, Gensheng Lu, Xiongfei Wu, et al.. (2012). Prulifloxacin versus Levofloxacin in the Treatment of Respiratory and Urinary Tract Infections: A Multicentre, Double-Blind, Randomized Controlled Clinical Trial. Chemotherapy. 58(3). 249–256. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026